The estimated Net Worth of Zvi Ben David is at least $303 Thousand dollars as of 28 February 2018. Mr. David owns over 9,018 units of DarioHealth Corp stock worth over $7,124 and over the last 9 years he sold DRIO stock worth over $0. In addition, he makes $295,594 as Chief Financial Officer, Treasurer, and Secretary at DarioHealth Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. David DRIO stock SEC Form 4 insiders trading
Zvi has made over 2 trades of the DarioHealth Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 9,018 units of DRIO stock worth $12,625 on 28 February 2018.
The largest trade he's ever made was buying 111,112 units of DarioHealth Corp stock on 8 March 2016 worth over $500,004. On average, Zvi trades about 3,875 units every 23 days since 2016. As of 28 February 2018 he still owns at least 9,018 units of DarioHealth Corp stock.
You can see the complete history of Mr. David stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Zvi Ben-David biography
Zvi Ben-David serves as Chief Financial Officer, Treasurer, Secretary of the Company. Mr. Ben David has over 25 years of experience in corporate and international financial management, including at both publicly-listed and private companies. Since 2012, he has acted as an independent entrepreneur with, and investor in, various medical device ventures. From 2005 to 2012, Mr. Ben David served as the Chief Financial Officer of UltraShape Medical Ltd., a developer, manufacturer and marketer of innovative non-invasive technologies for fat cell destruction and body sculpting. While with UltraShape, he helped lead the company through $35 million in private financing, followed by the company’s merger with a Tel Aviv Stock Exchange company and ultimately the company’s sale to Syneron Medical Ltd.. From 2000 to 2005, he served as Vice President and Chief Financial Officer of Given Imaging Ltd., where he was part of the management team that led that company’s 2001 initial public offering and 2004 follow-on offering, and served as a director of that company from its establishment in 1998 to 2000. From 1995 to June 2000, Mr. Ben David served as Vice President and Chief Financial Officer of RDC Rafael Development Corporation, one of Given Imaging Ltd.’s principal shareholders. From 1994 to 1995, Mr. Ben David served as manager of the finance division of Electrochemical Industries (Frutarom) Ltd., an Israeli company traded on the Tel-Aviv Stock Exchange and the American Stock Exchange, and from 1989 to 1993, Mr. Ben David served as the manager of that company’s economy and control department. From 1984 to 1988, Mr. Ben David worked at Avigosh & Kerbs, an accounting firm in Haifa, Israel. Mr. Ben David is a certified public accountant in Israel and holds a B.A. in economics and accounting from Haifa University.
What is the salary of Zvi David?
As the Chief Financial Officer, Treasurer, and Secretary of DarioHealth Corp, the total compensation of Zvi David at DarioHealth Corp is $295,594. There are 4 executives at DarioHealth Corp getting paid more, with Erez Raphael having the highest compensation of $1,382,200.
How old is Zvi David?
Zvi David is 59, he's been the Chief Financial Officer, Treasurer, and Secretary of DarioHealth Corp since 2015. There are 4 older and 12 younger executives at DarioHealth Corp. The oldest executive at DarioHealth Corp is Richard Stone, 77, who is the Independent Director.
What's Zvi David's mailing address?
Zvi's mailing address filed with the SEC is 322 W 57TH ST, #33B, , NEW YORK, NY, 10019.
Insiders trading at DarioHealth Corp
Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern, and Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.
What does DarioHealth Corp do?
DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.
What does DarioHealth Corp's logo look like?
Complete history of Mr. David stock trades at DarioHealth Corp
DarioHealth Corp executives and stock owners
DarioHealth Corp executives and other stock owners filed with the SEC include:
-
Erez Raphael,
Chief Executive Officer, Director -
Erez Raphael,
CEO & Director -
Richard A. Anderson,
Pres & GM of North America -
Dror Bacher,
Chief Operating Officer -
Zvi Ben-David,
Chief Financial Officer, Treasurer, Secretary -
Olivier Jarry,
Senior Vice President - Strategy and Business Development -
Dror Bacher,
Chief Operating Officer -
Zvi Ben David,
CFO, Treasurer & Sec. -
Richard Stone,
Independent Director -
Dennis McGrath,
Independent Director -
Hila Karah,
Independent Director -
Dennis Matheis,
Director -
Omar Manejwala,
Chief Medical Officer -
Barbara Stark,
Senior Vice President, Head of Managed Markets -
Adam Stern,
Director -
Yadin Shemmer,
Independent Director -
Richard Anderson,
President, General Manager - North America -
Allen Kamer,
Independent Director -
Yoav Shaked,
Independent Chairman of the Board -
Limor Drezner,
VP HR & Chief of Staff -
Josh Fischer,
Sr. VP of Operations & Compliance -
Yinon Amir,
Head of Software Innovation -
Jean Christophe Muyl,
Head of Commercialization North America -
Suzanne Bedell,
VP of Marketing -
Claudia Levi,
Content & Communications Mang. -
Dov Oppenheim,
Co-Founder & Production Chief -
Olivier R. Jarry,
Sr. VP of Strategy & Bus. Devel. -
Hod Rami Yehudiha,
Director -
Glen Moller,
Director -
Yalon Farhi,
Director -
Malcolm Hoenlein,
Director -
Ori Zanco,
Director -
Yossi Bahagon,
Director -
Shmuel Farhi,
10% owner -
Yossef Balucka,
CEO and President -
Oded Cohen,
GM MSK -
Jon H. Kaplan,
Director -
Tomer Ben Kiki,
Chief Operating Officer -
Steven Charles Nelson,
Chief Commercial Officer